Endoscopy and MRI for restaging early rectal cancer after neoadjuvant treatment.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2023 Vol.25(2) p. 211-221

Stijns RCH, Leijtens J, de Graaf E, Bach SP, Beets G, Bremers AJA, Beets-Tan RGH, de Wilt JHW

관련 도메인

Abstract

[AIM] Chemoradiotherapy (CRT) has great potential to downstage rectal cancer. Response assessment has been investigated in locally advanced rectal cancer but not in early stage rectal cancer. The aim is to characterize the diagnostic accuracy of endoscopy performed by surgical endoscopists compared to (diffusion-weighted, DWI) MRI only and a multimodal approach combining (DWI-)MRI and endoscopic information both analysed by an abdominal radiologist for response assessment in early rectal cancer after neoadjuvant CRT.

[MATERIALS AND METHODS] Patients treated with neoadjuvant CRT for early distal rectal cancer (cT1-3 N0) followed by transanal endoscopic microsurgery were included. Three separate reassessment groups were analysed for response assessment using endoscopic evaluation alone versus (DWI-)MRI alone versus the combination of endoscopy with (DWI-)MRI with a focus on sensitivity and specificity and analysis using receiver operating characteristic curves.

[RESULTS] Three cohorts (N = 36, N = 25 and N = 25, respectively) were analysed for response assessment. Of the endoscopy cohort, 16 of the 36 patients had a complete response. Area under the curve was 0.69 (0.66-0.74; pooled sensitivity 55.3%, pooled specificity 80.0%). Agreement for scoring separate endoscopic features was poor to moderate. Of the (DWI-)MRI cohort, 11 of the 25 patients had a complete response. Area under the curve for (DWI-)MRI alone was 0.55 (sensitivity 72.7%, specificity 42.9%). The areas under the receiver operating characteristic curve improved to 0.68 (sensitivity 90.9%, specificity 75.0%) when (DWI-)MRI was combined with endoscopic information, with 11 out of 25 patients with a complete response. The most accurate response assessment was made by combining endoscopy and (DWI-)MRI with a high negative predictive value (90.9%).

[CONCLUSION] Good and complete responders after chemoradiation of early stage rectal cancer can be best assessed using a multimodality approach combining endoscopy and (DWI-)MRI.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
기법 endoscopy 내시경 dict 6
기법 endoscopic 내시경 dict 5
시술 microsurgery 미세수술 dict 1
해부 abdominal scispacy 1
약물 neoadjuvant C0600558
Neoadjuvant Therapy
scispacy 1
약물 Chemoradiotherapy C0436307
Chemoradiotherapy
scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 rectal cancer scispacy 1
질환 CRT → Chemoradiotherapy scispacy 1
질환 cT1-3 N0 scispacy 1
기타 Patients scispacy 1

MeSH Terms

Humans; Neoadjuvant Therapy; Diffusion Magnetic Resonance Imaging; Treatment Outcome; Magnetic Resonance Imaging; Rectal Neoplasms; Chemoradiotherapy; Endoscopy, Gastrointestinal; Retrospective Studies

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문